Henry Schein

Q3 FY2026 EarningsQ3 FY26 results were slightly below consensus on the top line but beat on earnings, with revenue of $3.47B versus the $3.48B expected. Non-GAAP diluted EPS of $1.56 significantly exceeded the $1.36 estimate, aided by a $0.19 net tariff refund benefit. Strong U.S. dental merchandise sales (+8.6%) drove performance despite a decline in Global Value-Added Services. Management raised FY26 non-GAAP EPS guidance to $5.50–$5.56, surpassing the previous range of $5.29–$5.39.